Using Mass Spectrometry to Validate New Protein Variants from RNA-Seq Data
Author Information
Author(s): Ning Kang, Alexey I. Nesvizhskii
Primary Institution: University of Michigan
Hypothesis
Can mass spectrometry-based proteomics validate novel alternative splice forms identified from RNA-Seq data?
Conclusion
The study found that the ability to confirm novel alternative splice forms from mass spectrometry data was quite limited due to low abundance of many novel transcripts.
Supporting Evidence
- A significant correlation was observed between the likelihood of identifying a peptide from MS data and the number of reads in RNA-Seq data for the same gene.
- Only a fraction of novel alternative splice forms identified from RNA-Seq had corresponding junction peptides compatible with MS sequencing.
- The number of novel peptides identified from MS spectra was substantially lower than expected based on in silico analysis.
Takeaway
The researchers tried to see if they could find new proteins from RNA data using mass spectrometry, but they found it was really hard to do.
Methodology
The study used publicly available mouse tissue proteomic and RNA-Seq datasets to examine the feasibility of identifying novel alternative splice forms.
Limitations
The identification of novel peptides was lower than expected, and many novel transcripts were below the detection limit of mass spectrometry.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website